<Disease><Name>FRIEDREICH ATAXIA (FRDA)</Name><Synonym>FRDA</Synonym><OMIM><Number>229300</Number><URL>http://omim.org/entry/229300</URL></OMIM><Orphanet><Number>95</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=95</URL></Orphanet><Protein><Number>Frataxin, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/Q16595</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>9q21.11</Gene><ICD>G11.1</ICD><Summary>rare (1:50.000);autosomal recessive</Summary><Symptoms><symtomp><id>2470</id><symptom>areflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3062</id><symptom>diabetes mellitus</symptom><category>GASTROINTESTINAL SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1883</id><symptom>ECG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2389</id><symptom>Glucose tolerance, impaired</symptom><category>GENERAL TOPICS | LABORATORY FINDINGS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2250</id><symptom>skoliosis, kyphoskoliosis</symptom><category>BODY | SKELATAL DEFECT</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>4470</id><title>Friedreich Ataxia</title><author>Bidichandani SI,</author><journal>GeneReviews&#174; [Internet]</journal><year>2017</year><book>GeneReviews&#174; [Internet]</book><volume>0</volume><number>0</number><pages /><co_aut>Delatycki MB</co_aut></literature><literature><id>4471</id><title>Cardiac transplantation in Friedreich Ataxia: Extended follow-up</title><author>McCormick A,</author><journal>J Neurol Sci</journal><year>2017</year><book /><volume>375</volume><number>0</number><pages>471-473</pages><co_aut>et al.</co_aut></literature><literature><id>4472</id><title>Friedreich Ataxia: current status and future prospects</title><author>Buerk K</author><journal>Cerebellum Ataxias</journal><year>2017</year><book /><volume>4</volume><number>0</number><pages>4</pages><co_aut /></literature><literature><id>4473</id><title>Pharmacological treatments for Friedreich ataxia</title><author>Kearney M,</author><journal>Cochrane Database Syst Rev</journal><year>2016</year><book /><volume>8</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5188</id><title>Mitochondrial Cardiomyopathies</title><author>El-Hattab AW,</author><journal>Front Cardiovasc Med</journal><year>2016</year><book /><volume>3</volume><number>0</number><pages>25</pages><co_aut>Scaglia F</co_aut></literature><literature><id>2499</id><title>Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up</title><author>Hart PE</author><journal>Arch Neurol</journal><year>2005</year><book /><volume>62</volume><number>4</number><pages>621-626</pages><co_aut>et al.</co_aut></literature><literature><id>2500</id><title>Friedreichs ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative </title><author>Sturm B</author><journal>J Biol Chem</journal><year>2005</year><book /><volume>280</volume><number>8</number><pages>6701-6708</pages><co_aut>et al.</co_aut></literature><literature><id>2498</id><title>Friedreich ataxia: an overview</title><author>Delatycki MB</author><journal>J Med Genet</journal><year>2000</year><book /><volume>37</volume><number>1</number><pages>1,8</pages><co_aut>Williamson R, Forrest SM</co_aut></literature><literature><id>574</id><title>Childhood onset of Friedreich ataxia: a clinical and genetic study of 36 cases</title><author>de-Michele G</author><journal>Neuropediatrics</journal><year>1996</year><book /><volume>27</volume><number>1</number><pages>3-7</pages><co_aut>et al.</co_aut></literature><literature><id>575</id><title>The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13</title><author>Montermini L</author><journal>Am J Hum Genet</journal><year>1995</year><book /><volume>57</volume><number>5</number><pages>1061-1067</pages><co_aut>et al.</co_aut></literature><literature><id>576</id><title>Friedreichs ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial </title><author>Harding AE</author><journal>Brain</journal><year>1981</year><book /><volume>104</volume><number>0</number><pages>589-620</pages><co_aut /></literature></Literatures></Disease>